Department of Medicine and Research Center, Montreal Heart Institute, Université de Montréal, Canada.
J Mol Cell Cardiol. 2010 Jan;48(1):96-105. doi: 10.1016/j.yjmcc.2009.07.016. Epub 2009 Jul 23.
Membrane ion channels and transporters are key determinants of cardiac electrical function. Their expression is affected by cardiac region, hemodynamic properties, heart-rate changes, neurohormones and cardiac disease. One of the important determinants of ion-channel function is the level of ion-channel subunit mRNA expression, which governs the production of ion-channel proteins that traffic to the cell-membrane to form functional ion-channels. Ion-channel mRNA-expression profiling can be performed with cDNA microarrays or high-throughput reverse transcription/polymerase chain reaction (PCR) methods. Expression profiling has been applied to evaluate the dependence of ion-channel expression on cardiac region, revealing the molecular basis of regionally-controlled electrical properties as well as the molecular determinants of specialized electrical functions like pacemaking activity. Ion-channel remodeling occurs with cardiac diseases like heart failure, congenital repolarization abnormalities, and atrial fibrillation, and expression profiling has provided insights into the mechanisms by which these conditions affect cardiac electrical stability. Expression profiling has also shown how hormonal changes, antiarrhythmic drugs, cardiac development and altered heart rate affect ion-channel expression patterns to modify cardiac electrical function and sometimes to produce cardiac rhythm disturbances. This article reviews the information obtained to date with the application of cardiac ion-channel expression profiling. With increasing availability and efficiency of high-throughput PCR methods for ion-channel subunit mRNA-expression characterization, it is likely that the application of ion-channel expression profiling will increase and that it will provide important new insights into the determinants of cardiac electrical function in both physiological and pathological situations.
膜离子通道和转运蛋白是心脏电功能的关键决定因素。它们的表达受心脏区域、血液动力学特性、心率变化、神经激素和心脏疾病的影响。离子通道功能的一个重要决定因素是离子通道亚基 mRNA 表达水平,它控制着离子通道蛋白的产生,这些蛋白会转运到细胞膜上形成功能性离子通道。可以使用 cDNA 微阵列或高通量逆转录/聚合酶链反应 (PCR) 方法进行离子通道 mRNA 表达谱分析。表达谱分析已应用于评估离子通道表达对心脏区域的依赖性,揭示了区域控制电特性的分子基础,以及起搏活动等特殊电功能的分子决定因素。离子通道重构发生在心力衰竭、先天性复极化异常和心房颤动等心脏疾病中,表达谱分析提供了深入了解这些情况如何影响心脏电稳定性的机制。表达谱分析还表明,激素变化、抗心律失常药物、心脏发育和心率改变如何影响离子通道表达模式,以改变心脏电功能,有时会导致心脏节律紊乱。本文综述了迄今为止应用心脏离子通道表达谱分析所获得的信息。随着高通量 PCR 方法在离子通道亚基 mRNA 表达特征描述方面的日益普及和效率的提高,离子通道表达谱分析的应用很可能会增加,并为生理和病理情况下心脏电功能的决定因素提供重要的新见解。